Emergence of the ‘first-titled’ domestic vaccines attracted the depressed domestic market

2 vaccines, titled as the ‘first’ in the domestic market, appeared.

One of them is GSK’s ‘Fluarix Tetra,’ a tetravalent flu vaccine called as the next-generation vaccine. A number of tetravalent vaccines have been launched globally, but it is the only product approved in Korea.

Another one is SK Chemicals’ ‘Sky Cellflu,’ created by cell culture for the second time in the world, breaking the c...